ClinicalKey AI vs OpenEvidence (2026)
The publisher's answer against the newcomer's, and they are grounded in different things. ClinicalKey AI reads Elsevier's own curated library, enumerates it source by source, refreshes it daily and links each generated statement to the specific paragraph it came from, which is the best provenance mechanism in this category. OpenEvidence reads the current literature through partnerships with the New England Journal of Medicine, JAMA and Cochrane, and carries something no publisher owned product here has: eleven independent studies evaluating it, found through a systematic review it did not commission. The trade is the business model. Elsevier is paid by subscription and publishes no price. OpenEvidence is free because pharmaceutical and device advertising sits beside the answers, governed by a published policy that is worth reading before you decide the trade is acceptable.
- Provenance runs to the paragraph. A generated answer links to the specific passage in the source it came from rather than to the document, which is the finest granularity available in this category.
- The corpus is enumerated rather than described, with named reference texts, society guidelines from bodies spanning cardiology, endocrinology and emergency medicine, named journals and government publications, refreshed daily.
- A published clinician centred evaluation framework applied to its own generative output, plus five responsible AI principles, available in more than 50 countries with multi language support.
- Eleven independent studies published between 2024 and 2026 evaluating this product, identified through a systematic review following PRISMA, which is external scrutiny no publisher owned product here has attracted.
- It reaches the current literature rather than a back catalogue, through official partnerships with the New England Journal of Medicine, JAMA and its eleven specialty journals, and Cochrane Systematic Reviews.
- Free to verified United States clinicians with web and native mobile applications, plus enterprise Epic embedding documented at Mount Sinai across seven hospitals, against a product whose only published price is a free year for students.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. ClinicalKey AI and OpenEvidence are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | ClinicalKey AI | OpenEvidence |
|---|---|---|
| Primary category | Clinical Reference & Evidence | Clinical Reference & Evidence |
| Founded | Not recorded | 2021 |
| Headquarters | New York, New York | Miami, Florida |
| Website | elsevier.com | openevidence.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards ClinicalKey AI its top capability grade on Autonomy and Oversight Model and Model Supply Chain Disclosure. Set against OpenEvidence, ClinicalKey AI grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards OpenEvidence its top capability grade on AI Centrality and Security Certifications and Trust Center. Set against ClinicalKey AI, OpenEvidence grades higher on several axes, including AI Centrality, HIPAA and BAA Posture and Security Certifications and Trust Center. Its thinnest published disclosure sits on AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose ClinicalKey AI or OpenEvidence?
On the axes where the AI Health Index separates them, ClinicalKey AI grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure, and OpenEvidence grades higher on several axes, including AI Centrality, HIPAA and BAA Posture and Security Certifications and Trust Center. ClinicalKey AI leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do ClinicalKey AI and OpenEvidence differ most?
The widest separation the AI Health Index records between ClinicalKey AI and OpenEvidence is on Model Supply Chain Disclosure, where ClinicalKey AI grades A and OpenEvidence grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do ClinicalKey AI and OpenEvidence grade the same?
The AI Health Index grades ClinicalKey AI and OpenEvidence the same on several axes, including Clinical and Operational Evidence, AI Safety and PHI Stewardship and FDA and Regulatory Status. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have ClinicalKey AI and OpenEvidence not disclosed?
At the last review, at least one of ClinicalKey AI and OpenEvidence published thin or absent detail on AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
OpenEvidence is funded by pharmaceutical and medical device advertising shown alongside clinical answers, and its published advertising policy is the artifact to read before deciding whether that is acceptable in your setting. ClinicalKey AI publishes no rate card and no security attestation or trust centre, and its HIPAA claim carries a qualifier rather than an inspectable agreement.
Neither product publishes a bias evaluation, subgroup performance analysis or error taxonomy for the generative layer, which is the shared gap in this category: both address the fabricated citation well and neither addresses an interpretive error sitting underneath an accurate one.